TXO Partners, L.P. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TXO Partners, L.P. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $401.01M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $282.81M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $380.72M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $246.40M | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $228.34M | Mar 5, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $363.15M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $285.38M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $357.54M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $449.61M | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $219.37M | Mar 5, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($21.62M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $23.50M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | ($103.99M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | ($7.67M) | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $52.48M | Mar 5, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($30.58M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($6.86M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | ($123.78M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | ($25.68M) | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $44.19M | Mar 5, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $118.19M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $109.30M | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | $77.15M | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $136.38M | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | $73.73M | Mar 5, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.35B | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.03B | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $695.61M | Mar 4, 2025 |
| FY2023 | Dec 31, 2022 | $924.63M | Mar 5, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.37M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $7.31M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $4.51M | Mar 4, 2025 |
| FY2023 | Dec 31, 2022 | $9.20M | Mar 5, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $291.10M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $157.10M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $28.10M | Mar 4, 2025 |
| FY2023 | Dec 31, 2022 | $120.10M | Mar 5, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 5, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | (3) | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 4, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 5, 2024 |